Central precocious puberty with hypothalamic hamartoma: the first case reports of 2 siblings with different phenotypes of Seckel syndrome 5
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hypothalamic hamartomas (HHs) are nonneoplastic mass lesions located in the hypothalamus that can cause central precocious puberty (CPP) and/or gelastic seizures. Seckel syndrome 5 (OMIM210600, SCKL5) is a rare autosomal recessive genetic spectrum disorder characterized by intrauterine growth retardation, proportionate osteodysplastic primordial dwarfism, a wide range of intellectual disability, "bird-headed" facial features, and microcephaly with various structural brain abnormalities. Two siblings presented with short stature and small head circumference and were diagnosed with SCKL 5. The younger sister had HH with CPP and experienced a slipped capital femoral epiphysis during treatment. The 2 siblings had the same genetic variant but showed different phenotypes, which has not been reported previously; this study also as presents the first cases of SCKL5 diagnosed by genetic confirmation in Korea.
Abstract
Hypothalamic hamartomas (HHs) are nonneoplastic mass lesions located in the hypothalamus that can cause central precocious puberty (CPP) and/or gelastic seizures. Seckel syndrome 5 (OMIM210600, SCKL5) is a rare autosomal recessive genetic spectrum disorder characterized by intrauterine growth retardation, proportionate osteodysplastic primordial dwarfism, a wide range of intellectual disability, "bird-headed" facial features, and microcephaly with various structural brain abnormalities. Two siblings presented with short stature and small head circumference and were diagnosed with SCKL 5. The younger sister had HH with CPP and experienced a slipped capital femoral epiphysis during treatment. The 2 siblings had the same genetic variant but showed different phenotypes, which has not been reported previously; this study also as presents the first cases of SCKL5 diagnosed by genetic confirmation in Korea.
참고문헌 (15)
- Arita K, "The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamartoma", J Neurosurg, 91, pp.212~220 (1999)
- Kerrigan JF, "Hypothalamic hamartoma : Neuropathology and epileptogenesis", Epilepsia, 58, pp.22~31 (2017)
- Khojah O, "Central nervous system vasculopathy and Seckel syndrome : case illustration and systematic review", Childs Nerv Syst, 37, pp.3847~3860 (2021)
- Faivre L, "Clinical and genetic heterogeneity of Seckel syndrome", Am J Med Genet, 112, pp.379~383 (2002)
- Nigg EA, "Centrioles, centrosomes, and cilia in health and disease", Cell, 139, pp.663~678 (2009)
- Capovilla G, "Seckel's syndrome and malformations of cortical development : report of three new cases and review of the literature", J Child Neurol, 16, pp.382~386 (2001)
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
- Savage Martin Oswald, "Balanced assessment of growth disorders using clinical, endocrinological, and genetic approaches", Annals of Pediatric Endocrinology & Metabolism, 26(4), pp.218~226 (2021), 대한소아내분비학회[DOI]
- Green TE, "Sporadic hypothalamic hamartoma is a ciliopathy with somatic and bi-allelic contributions", Hum Mol Genet, 31, pp.2307~2316 (2022)
- Jaiswal S, "Centrosome dysfunction in human diseases", Semin Cell Dev Biol, 110, pp.113~122 (2021)
- Huynh Quynh Thi Vu, "Pathological brain lesions in girls with central precocious puberty at initial diagnosis in Southern Vietnam", Annals of Pediatric Endocrinology & Metabolism, 27(2), pp.105~112 (2022), 대한소아내분비학회[DOI]
- Birkebaek NH, "Growth hormone treatment, final height, insulin-like growth factors, ghrelin, and adiponectin in four siblings with Seckel syndrome", J Pediatr Endocrinol Metab, 24, pp.995~1000 (2011)
- Inman M, "Occurrence of slipped capital femoral epiphysis in children undergoing gonadotropin-releasing hormone agonist therapy for the treatment of central precocious puberty", Horm Res Paediatr, 80, pp.64~68 (2013)
- Wang SY, "Slipped capital femoral epiphysis as a complication of growth hormone therapy", J Formos Med Assoc, 106(2Suppl), pp.S46~S50 (2007)
- Lee JW, "Significant adverse reactions to long-acting gonadotropinreleasing hormone agonists for the treatment of central precocious puberty and early onset puberty", Ann Pediatr Endocrinol Metab, 19, pp.135~140 (2014)